These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8816616)

  • 1. Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing.
    Avivi I; Pollack S; Gideoni O; Linn S; Blumenfeld Z
    Fertil Steril; 1996 Oct; 66(4):557-63. PubMed ID: 8816616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset adrenal hyperplasia in north Indian hirsute women.
    Mithal A; Ammini AC; Godbole MM; Khurana ML; Raj D; Karmarkar MG; Ahuja MM
    Horm Res; 1988; 30(1):1-4. PubMed ID: 2851524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Phocas I; Chryssikopoulos A; Sarandakou A; Rizos D; Trakakis E
    Gynecol Endocrinol; 1995 Sep; 9(3):229-38. PubMed ID: 8540293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women.
    Chetkowski RJ; DeFazio J; Shamonki I; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):595-8. PubMed ID: 6321532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.
    Chryssikopoulos A; Phocas I; Sarandakou A; Trakakis E; Rizos D
    J Endocrinol Invest; 1995 Nov; 18(10):754-61. PubMed ID: 8787951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome.
    Trakakis E; Rizos D; Loghis C; Chryssikopoulos A; Spyropoulou M; Salamalekis E; Simeonides G; Vagopoulos V; Salamalekis G; Kassanos D
    Endocr J; 2008 Mar; 55(1):33-9. PubMed ID: 18187875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
    Lobo RA; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
    Azziz R; Zacur HA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital adrenal hyperplasia family studies using the short ACTH test.
    Kreutzmann DJ; Cowell CT; Howard NJ; De Souza M; Silink M
    Aust Paediatr J; 1989 Dec; 25(6):340-5. PubMed ID: 2619637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
    Markantes G; Saltamavros AD; Vervita V; Armeni AK; Karela A; Adonakis G; Decavalas G; Georgopoulos NA
    Gynecol Endocrinol; 2011 Dec; 27(12):971-7. PubMed ID: 21501001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC; Elias LL
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee PA; Rosenwaks Z; Urban MD; Migeon CJ; Bias WD
    J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
    Benjamin F; Deutsch S; Saperstein H; Seltzer VL
    Fertil Steril; 1986 Aug; 46(2):215-21. PubMed ID: 3015693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
    Kamel N; Tonyukuk V; Emral R; Corapçioğlu D; Baştemir M; Güllü S
    Endocr J; 2003 Dec; 50(6):815-23. PubMed ID: 14709856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation and evidence for CYP21B gene point mutations in true precocious puberty.
    Cisternino M; Dondi E; Martinetti M; Lorini R; Salvaneschi L; Cuccia M; Severi F
    Clin Endocrinol (Oxf); 1998 May; 48(5):555-60. PubMed ID: 9666866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.